Wolverine Asset Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,405
Closed -$1.07M 1512
2016
Q4
$1.07M Buy
1,405
+1,311
+1,395% +$991K 0.01% 518
2016
Q3
$77K Sell
94
-1,658
-95% -$1.43M ﹤0.01% 1004
2016
Q2
$1.46M Buy
1,752
+1,534
+704% +$1.28M 0.02% 497
2016
Q1
$199K Sell
218
-6,187
-97% -$5.92M 0.01% 663
2015
Q4
$6.57M Sell
6,405
-31,311
-83% -$31.4M 0.14% 139
2015
Q3
$35.7M Buy
37,716
+4,000
+12% +$4.17M 0.84% 23
2015
Q2
$35.2M Buy
+33,716
New +$35.3M 0.8% 29

Other funds holding AGN.PRA

Wolverine Asset Management's AGN.PRA Position: Q1 2017 in Review

Wolverine Asset Management sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 1,405 shares — an estimated $1.07M sold.

Wolverine Asset Management first reported a position in AGN.PRA in Q2 2015 and held it in 7 quarters. The position peaked at $35.7M in Q3 2015. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

  • Wolverine Asset Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Wolverine Asset Management sold 1,405 Allergan plc shares in Q1 2017, an estimated $1.07M.
  • Wolverine Asset Management first reported a position in Allergan plc in Q2 2015 and held it in 7 quarters.
  • Wolverine Asset Management's Allergan plc position peaked at $35.7M in Q3 2015.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Wolverine Asset Management's 13F filing for Q1 2017, filed 15 May 2017.